Thus, while persistent NRF2 activation equips cancer cells with a robust defense against oxidative stress, it simultaneously necessitates metabolic adaptations to fulfill altered demands for specific metabolites and mitigate associated trade-offs (Romero et al, 2017; LeBoeuf et al, 2020; Ding et al, 2021). Here, NFE2L2 is linked to cancer.